Sedentary modern lifestyle has given rise to unhealthy food habits
that increase the intake of medicines. One of the major health
conditions that increases medicine intake is high blood pressure which
increases the acid level in the stomach. Antacids are required to deal
with the increased acidity levels. Manufacturers in the global antacids market are focused to develop drug formulations that are customer centric i.e.
they are easy to consume. Chewable and flavored medicines are preferred
by the consumers for their ease of consumption by any age group and at
any instant of time.
Fact.MR report predicts the global antacids
market to amount US$19Bn by the end of the year 2025. Easy regulations
for over the counter available antacids increase penetration of these
antacids in market. Various distribution channels including retail
pharmacies, hospital pharmacies and convenience stores are engaged in
sale of antacids. Manufacturers are constantly developing more efficient
antacids to create their unique image in market.
Proton pump inhibitors are common antacids
Proton
pump inhibitors are the standard antacids that are used to treat
gastroesophageal reflux disease. However, these drugs are only adviced
to be used for a short time as prolonged consumption can adversely
impact various body parts including kidney. It also has the potential to
inhibit vitamin B12 absorption. Consumption of proton pump inhibitors
in high dosage for long time increases risk of various health conditions
including hip and spine fractures. Awareness regarding these side
effects is increasing which is expected to increase production of
various components like H2 Antagonist and neutralizers for acids. Both
of these are gaining grounds in antacids market as proton pump inhibitor
substitute.
Consumers
are getting inclined towards natural therapeutics to reduce the side
effects of antibiotics. Ayurveda and Chinese treatments have surfaced as
great natural therapeutics options. The major factor behind popularity
of these alternative treatments is use of house hold ingredients that
are cost effective. This growing preference for natural therapeutics is
anticipated to inhibit the market growth of global antacids market.
Gummies format is new in market
Antacids
are also getting popular for their convenience. Tablet format is sought
after by the customers and its sale is projected to be US$13Bn by the
end of year 2025. GERD patients are the primary customers of tablet
antacids and they prefer this form for its benefits like administered
dosage, easy consumption and convenience of storage. Manufacturers are
introducing tablet formats for leading drug classes. The other formats
include melt in mouth and gummies that are gaining rapid traction. They
formulations are forecasted to grow at ̴5% CAGR during the forecasts
period.
Major distribution channels in antacids market include
retail pharmacies and online pharmacies. Growing usage of e-commerce
channels along with the option of doorstep delivery is evolving online
pharmacy as mainstream distribution channel of antacids. Europe leads
the global market and owns one third of the market share. Online
pharmacies are generating major sales owing to the high smartphone
penetration and growing online-shopping culture.
Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4328
Share This
Email
Facebook
Twitter
Read Request
My Library
Subscribe
Flag Writing
